{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:12:47Z","timestamp":1789150367264,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03534-z","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:59:32Z","timestamp":1789149572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing Curcumin Performance via PVP K30 Solid Dispersion: Synergistic Potential in Combination with Conventional Chemotherapeutic Agents in NSCLC Cells"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9419-2669","authenticated-orcid":false,"given":"Daniel","family":"Hernandez-Patlan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8686-0946","authenticated-orcid":false,"given":"Elvia A. Morales","family":"Hip\u00f3lito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3275-5526","authenticated-orcid":false,"given":"Carla O.","family":"Contreras-Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7141-0129","authenticated-orcid":false,"given":"Marisol","family":"Mir-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7043-7166","authenticated-orcid":false,"given":"Hugo Cort\u00e9s","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1319-6121","authenticated-orcid":false,"given":"Adriana","family":"Tejeda-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4323-394X","authenticated-orcid":false,"given":"Sandra L.","family":"Hern\u00e1ndez-Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6406-7763","authenticated-orcid":false,"given":"Javier J.","family":"Espinosa-Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2050-6119","authenticated-orcid":false,"given":"Raquel","family":"L\u00f3pez-Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"3534_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.21037\/tlcr-23-691","volume":"13","author":"ME Poh","year":"2024","unstructured":"Poh ME, Chai CS, Liam CK, Ho GF, Pang YK, Hasbullah HH, et al. Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice? Transl Lung Cancer Res. 2024;13:307. https:\/\/doi.org\/10.21037\/tlcr-23-691.","journal-title":"Transl Lung Cancer Res"},{"key":"3534_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/inorganics13070246","author":"A Mariconda","year":"2025","unstructured":"Mariconda A, Ceramella J, Catalano A, Saturnino C, Sinicropi MS, Longo P. Cisplatin, the timeless molecule. Inorganics. 2025. https:\/\/doi.org\/10.3390\/inorganics13070246.","journal-title":"Inorganics"},{"key":"3534_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168885","volume":"22","author":"J Kryczka","year":"2021","unstructured":"Kryczka J, Kryczka J, Czarnecka-Chrebelska KH, Brzezia\u0144ska-Lasota E. Molecular mechanisms of chemoresistance induced by cisplatin in NSCLC cancer therapy. Int J Mol Sci. 2021;22:8885. https:\/\/doi.org\/10.3390\/ijms22168885.","journal-title":"Int J Mol Sci"},{"key":"3534_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10608","volume":"8","author":"R Ranasinghe","year":"2022","unstructured":"Ranasinghe R, Mathai ML, Zulli A. Cisplatin for cancer therapy and overcoming chemoresistance. Heliyon. 2022;8:e10608. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10608.","journal-title":"Heliyon"},{"key":"3534_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115891","volume":"169","author":"Y Li","year":"2023","unstructured":"Li Y, Yan B, He S. Advances and challenges in the treatment of lung cancer. Biomed Pharmacother. 2023;169:115891. https:\/\/doi.org\/10.1016\/j.biopha.2023.115891.","journal-title":"Biomed Pharmacother"},{"key":"3534_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87537-z","volume":"15","author":"H Xia","year":"2025","unstructured":"Xia H, Tai X, Cheng W, Wu Y, He D, Wang L, et al. Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling. Sci Rep. 2025;15:6081. https:\/\/doi.org\/10.1038\/s41598-025-87537-z.","journal-title":"Sci Rep"},{"key":"3534_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2023.1062830","volume":"14","author":"S Oliveri","year":"2023","unstructured":"Oliveri S, Lanzoni L, Veldwijk J, de Wit GA, Petrocchi S, Janssens R, et al. Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives. Front Psychol. 2023;14:1062830. https:\/\/doi.org\/10.3389\/fpsyg.2023.1062830.","journal-title":"Front Psychol"},{"key":"3534_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16142580","volume":"16","author":"A Amaroli","year":"2024","unstructured":"Amaroli A, Panfoli I, Bozzo M, Ferrando S, Candiani S, Ravera S. The bright side of curcumin: a narrative review of its therapeutic potential in cancer management. Cancers (Basel). 2024;16:2580. https:\/\/doi.org\/10.3390\/cancers16142580.","journal-title":"Cancers (Basel)"},{"key":"3534_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612587","volume":"24","author":"NA Cacciola","year":"2023","unstructured":"Cacciola NA, Cuciniello R, Petillo GD, Piccioni M, Filosa S, Crispi S. An overview of the enhanced effects of curcumin and chemotherapeutic agents in combined cancer treatments. Int J Mol Sci. 2023;24:12587. https:\/\/doi.org\/10.3390\/ijms241612587.","journal-title":"Int J Mol Sci"},{"key":"3534_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01021","author":"J Sharifi-Rad","year":"2020","unstructured":"Sharifi-Rad J, Rayess YE, Rizk AA, Sadaka C, Zgheib R, Zam W, et al. Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications. Front Pharmacol. 2020. https:\/\/doi.org\/10.3389\/fphar.2020.01021.","journal-title":"Front Pharmacol"},{"key":"3534_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28093746","volume":"28","author":"C Jakobu\u0161i\u0107 Brala","year":"2023","unstructured":"Jakobu\u0161i\u0107 Brala C, Karkovi\u0107 Markovi\u0107 A, Kugi\u0107 A, Tori\u0107 J, Barbari\u0107 M. Combination chemotherapy with selected polyphenols in preclinical and clinical studies\u2014an update overview. Molecules. 2023;28:3746. https:\/\/doi.org\/10.3390\/molecules28093746.","journal-title":"Molecules"},{"key":"3534_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122102","author":"S-I Sohn","year":"2021","unstructured":"Sohn S-I, Priya A, Balasubramaniam B, Muthuramalingam P, Sivasankar C, Selvaraj A, et al. Biomedical applications and bioavailability of curcumin-an updated overview. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13122102.","journal-title":"Pharmaceutics"},{"key":"3534_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01289","volume":"9","author":"D Hernandez-Patlan","year":"2018","unstructured":"Hernandez-Patlan D, Solis-Cruz B, Pontin KP, Latorre JD, Baxter MFA, Hernandez-Velasco X, et al. Evaluation of a solid dispersion of curcumin with polyvinylpyrrolidone and boric acid against Salmonella enteritidis infection and intestinal permeability in broiler chickens: a pilot study. Front Microbiol. 2018;9:1289. https:\/\/doi.org\/10.3389\/fmicb.2018.01289.","journal-title":"Front Microbiol"},{"key":"3534_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.13040\/IJPSR.0975-8232.15(2).340-52","volume":"15","author":"NM Hande","year":"2024","unstructured":"Hande NM. Solid dispersion: Strategies to enhance solubility and dissolution rate of poorly water-soluble drug. Int J Pharm Sci Res. 2024;15:340\u201352. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.15(2).340-52.","journal-title":"Int J Pharm Sci Res"},{"key":"3534_CR15","doi-asserted-by":"publisher","unstructured":"de Oliveira Cardoso Melo ME, Castro da Silva C, dos Santos Dantas T, Barbosa Machado JC, Assun\u00e7\u00e3o Ferreira MR, Lira Soares LA. Amorphous solid dispersions as a strategy to enhance the bioavailability and stability of formulations containing plant active ingredients: An integrative review. DARU J Pharm Sci. 2026;34:19. https:\/\/doi.org\/10.1007\/s40199-026-00594-1","DOI":"10.1007\/s40199-026-00594-1"},{"key":"3534_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ph19040598","author":"N Rosiak","year":"2026","unstructured":"Rosiak N, Ignacyk M, Kryszak A, Piontek J, Cielecka-Piontek J. Amorphous solid dispersions of polyphenols: current state of the art (part I). Pharmaceuticals. 2026. https:\/\/doi.org\/10.3390\/ph19040598.","journal-title":"Pharmaceuticals"},{"key":"3534_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11090442","author":"Y He","year":"2019","unstructured":"He Y, Liu H, Bian W, Liu Y, Liu X, Ma S, et al. Molecular interactions for the curcumin-polymer complex with enhanced anti-inflammatory effects. Pharmaceutics. 2019. https:\/\/doi.org\/10.3390\/pharmaceutics11090442.","journal-title":"Pharmaceutics"},{"key":"3534_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/10717544.2020.1785051","volume":"27","author":"Y Deng","year":"2020","unstructured":"Deng Y, Chen C, Xiao Z, Huang X, Xu J. Enhanced anti-hepatoma effect of a novel curcumin analog C086 via solid dispersion technology. Drug Deliv. 2020;27:927\u201337. https:\/\/doi.org\/10.1080\/10717544.2020.1785051.","journal-title":"Drug Deliv"},{"key":"3534_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijpharm.2003.11.014","volume":"271","author":"A Paradkar","year":"2004","unstructured":"Paradkar A, Ambike AA, Jadhav BK, Mahadik KR. Characterization of curcumin\u2013PVP solid dispersion obtained by spray drying. Int J Pharm. 2004;271:281\u20136. https:\/\/doi.org\/10.1016\/j.ijpharm.2003.11.014.","journal-title":"Int J Pharm"},{"key":"3534_CR20","first-page":"278","volume":"20","author":"European Medicines Agency","year":"1995","unstructured":"European Medicines Agency. ICH Topic Q 2 (R1) validation of analytical procedures: text and methodology. Prescrire Int. 1995;20:278.","journal-title":"Prescrire Int"},{"key":"3534_CR21","unstructured":"Food and Drug Administration. Analytical procedures and methods validation for drugs and biologics. US Dep Heal Hum Serv. 2015. https:\/\/www.fda.gov\/media\/87801\/download."},{"key":"3534_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5916013","volume":"2022","author":"R Malkawi","year":"2022","unstructured":"Malkawi R, Malkawi WI, Al-Mahmoud Y, Tawalbeh J. Current trends on solid dispersions: past, present, and future. Adv Pharmacol Pharm Sci. 2022;2022:5916013. https:\/\/doi.org\/10.1155\/2022\/5916013.","journal-title":"Adv Pharmacol Pharm Sci"},{"key":"3534_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep40752","volume":"7","author":"L Huang","year":"2017","unstructured":"Huang L, Jiang Y, Chen Y. Predicting drug combination index and simulating the network-regulation dynamics by mathematical modeling of drug-targeted EGFR-ERK signaling pathway. Sci Rep. 2017;7:40752. https:\/\/doi.org\/10.1038\/srep40752.","journal-title":"Sci Rep"},{"key":"3534_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29225321","author":"J Kuzminska","year":"2024","unstructured":"Kuzminska J, Szyk P, Mlynarczyk DT, Bakun P, Muszalska-Kolos I, Dettlaff K, et al. Curcumin derivatives in medicinal chemistry: potential applications in cancer treatment. Molecules. 2024. https:\/\/doi.org\/10.3390\/molecules29225321.","journal-title":"Molecules"},{"key":"3534_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34636","volume":"10","author":"M Ishtiaq","year":"2024","unstructured":"Ishtiaq M, Manzoor H, Khan IU, Asghar S, Irfan M, Albekairi NA, et al. Curcumin-loaded soluplus\u00ae based ternary solid dispersions with enhanced solubility, dissolution and antibacterial, antioxidant, anti-inflammatory activities. Heliyon. 2024;10:e34636. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34636.","journal-title":"Heliyon"},{"key":"3534_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26020855","author":"E Garbiec","year":"2025","unstructured":"Garbiec E, Rosiak N, Sip S, Zalewski P, Cielecka-Piontek J. Curcumin solubility and bioactivity enhancement through amorphization with tryptophan via supercritical fluid technology. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26020855.","journal-title":"Int J Mol Sci"},{"key":"3534_CR27","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4801178","volume":"99","author":"W Tiatragoon","year":"2024","unstructured":"Tiatragoon W, Laffleur F, Netsomboon K. Development of curcumin-loaded lipid nanocapsules for drug delivery across mucus. J Drug Deliv Sci Technol. 2024;99:106014. https:\/\/doi.org\/10.2139\/ssrn.4801178.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3534_CR28","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s10337-020-03946-4","volume":"83","author":"S Mohammadi","year":"2020","unstructured":"Mohammadi S, Haghighi Asl A, Mottahedin P. Experiments, correlation, and modeling of curcumin solubility in subcritical water (water\/ethanol). Chromatographia. 2020;83:1293\u2013305. https:\/\/doi.org\/10.1007\/s10337-020-03946-4.","journal-title":"Chromatographia"},{"key":"3534_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejps.2016.01.026","volume":"85","author":"MB Rask","year":"2016","unstructured":"Rask MB, Knopp MM, Olesen NE, Holm R, Rades T. Influence of PVP\/VA copolymer composition on drug\u2013polymer solubility. Eur J Pharm Sci. 2016;85:10\u20137. https:\/\/doi.org\/10.1016\/j.ejps.2016.01.026.","journal-title":"Eur J Pharm Sci"},{"key":"3534_CR30","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3109\/10837450.2013.846374","volume":"19","author":"LA Wegiel","year":"2014","unstructured":"Wegiel LA, Zhao Y, Mauer LJ, Edgar KJ, Taylor LS. Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability. Pharm Dev Technol. 2014;19:976\u201386. https:\/\/doi.org\/10.3109\/10837450.2013.846374.","journal-title":"Pharm Dev Technol"},{"key":"3534_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061601","author":"AB Odeh","year":"2023","unstructured":"Odeh AB, El-Sayed B, Knopp MM, Rades T, Blaabjerg LI. Influence of polyvinylpyrrolidone molecular weight and concentration on the precipitation inhibition of supersaturated solutions of poorly soluble drugs. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15061601.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3534_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/separations10020098","volume":"10","author":"N Haq","year":"2023","unstructured":"Haq N, Shakeel F, Ghoneim MM, Asdaq SM, Alam P, Alanazi SA, et al. Greener stability-indicating HPLC approach for the determination of curcumin in in-house developed nanoemulsion and Curcuma longa L. extract. Separations. 2023;98. https:\/\/doi.org\/10.3390\/separations10020098.","journal-title":"Separations"},{"key":"3534_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21101386","volume":"21","author":"I-S Song","year":"2016","unstructured":"Song I-S, Cha J-S, Choi M-K. Characterization, in vivo and in vitro evaluation of solid dispersion of curcumin containing d-\u03b1-Tocopheryl polyethylene glycol 1000 succinate and mannitol. Molecules. 2016;21:1386. https:\/\/doi.org\/10.3390\/molecules21101386.","journal-title":"Molecules"},{"key":"3534_CR34","doi-asserted-by":"publisher","unstructured":"Hernandez-Patlan D, Solis-Cruz B, Latorre JD, Maguey-Gonzalez JA, Castellanos-Huerta I, Beyssac E, et al. Evaluation of the Antimicrobial Activity of a Formulation Containing Ascorbic Acid and Eudragit FS 30D Microparticles for the Controlled Release of a Curcumin\u2013Boric Acid Solid Dispersion in Turkey Poults Infected with Salmonella\u00a0enteritidis: A Therapeutic. Int J Mol Sci 2023;16186. https:\/\/doi.org\/10.3390\/ijms242216186","DOI":"10.3390\/ijms242216186"},{"key":"3534_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/adem.201900796","author":"F Lanyi","year":"2019","unstructured":"Lanyi F, Wenzke N, Kaschta J, Schubert D. On the determination of the enthalpy of fusion of \u03b1\u2010crystalline isotactic polypropylene using differential scanning calorimetry, X\u2010ray diffraction, and Fourier\u2010transform infrared spectroscopy: an old story revisited. Adv Eng Mater. 2019. https:\/\/doi.org\/10.1002\/adem.201900796.","journal-title":"Adv Eng Mater"},{"key":"3534_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101682","author":"R Iyer","year":"2021","unstructured":"Iyer R, Petrovska Jovanovska V, Berginc K, Jakli\u010d M, Fabiani F, Harlacher C, et al. Amorphous solid dispersions (ASDs): the influence of material properties, manufacturing processes and analytical technologies in drug product development. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13101682.","journal-title":"Pharmaceutics"},{"key":"3534_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejps.2013.03.018","volume":"50","author":"D Hasa","year":"2013","unstructured":"Hasa D, Voinovich D, Perissutti B, Grassi G, Fiorentino S, Farra R, et al. Reduction of melting temperature and enthalpy of drug crystals: theoretical aspects. Eur J Pharm Sci. 2013;50:17\u201328. https:\/\/doi.org\/10.1016\/j.ejps.2013.03.018.","journal-title":"Eur J Pharm Sci"},{"key":"3534_CR38","doi-asserted-by":"publisher","first-page":"37264","DOI":"10.1021\/acsomega.2c03495","volume":"7","author":"DC Manatunga","year":"2022","unstructured":"Manatunga DC, Jayasinghe JAB, Sandaruwan C, De Silva RM, De Silva KMN. Enhancement of release and solubility of curcumin from electrospun PEO-EC-PVP tripolymer-based nanofibers: a study on the effect of hydrogenated castor oil. ACS Omega. 2022;7:37264\u201378. https:\/\/doi.org\/10.1021\/acsomega.2c03495.","journal-title":"ACS Omega"},{"key":"3534_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/polym13234073","author":"H Mashaqbeh","year":"2021","unstructured":"Mashaqbeh H, Obaidat R, Al-Shar\u2019i N. Evaluation and characterization of curcumin-\u03b2-cyclodextrin and cyclodextrin-based nanosponge inclusion complexation. Polymers. 2021. https:\/\/doi.org\/10.3390\/polym13234073.","journal-title":"Polymers"},{"key":"3534_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119560","volume":"586","author":"P Pandi","year":"2020","unstructured":"Pandi P, Bulusu R, Kommineni N, Khan W, Singh M. Amorphous solid dispersions: an update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products. Int J Pharm. 2020;586:119560. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119560.","journal-title":"Int J Pharm"},{"key":"3534_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125331","volume":"672","author":"D Martynek","year":"2025","unstructured":"Martynek D, Ridvan L, Siv\u00e9n M, \u0160o\u00f3\u0161 M. Stability and recrystallization of amorphous solid dispersions prepared by hot-melt extrusion and spray drying. Int J Pharm. 2025;672:125331. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125331.","journal-title":"Int J Pharm"},{"key":"3534_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14080983","volume":"14","author":"X Hern\u00e1ndez Mart\u00ednez","year":"2025","unstructured":"Hern\u00e1ndez Mart\u00ednez X, Contreras-Ochoa CO, Mir-Garcia M, Aguilar-Garc\u00eda N, Cort\u00e9s Mart\u00ednez H, Morales-Hip\u00f3lito EA, et al. Development and in vitro cytotoxicity evaluation of individual and combined injectable solutions of curcumin and resveratrol against lung cancer cells. Antioxidants (Basel). 2025;14:983. https:\/\/doi.org\/10.3390\/antiox14080983.","journal-title":"Antioxidants (Basel)"},{"key":"3534_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/fcp.12835","volume":"37","author":"T-Y Tsai","year":"2023","unstructured":"Tsai T-Y, Chen C-Y, Shiao L-R, Ou T-T, Wu C-H, Leung Y-M, et al. Afatinib triggers a Ni(2+) -resistant Ca(2+) influx pathway in A549 non-small cell lung cancer cells. Fundam Clin Pharmacol. 2023;37:253\u201362. https:\/\/doi.org\/10.1111\/fcp.12835.","journal-title":"Fundam Clin Pharmacol"},{"key":"3534_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030381","volume":"15","author":"P Barrios-Bernal","year":"2022","unstructured":"Barrios-Bernal P, Hernandez-Pedro N, Orozco-Morales M, Viedma-Rodr\u00edguez R, Lucio-Lozada J, Avila-Moreno F, et al. Metformin enhances TKI-Afatinib cytotoxic effect, causing downregulation of glycolysis, epithelial\u2013mesenchymal transition, and EGFR-signaling pathway activation in lung cancer cells. Pharmaceuticals (Basel). 2022;15:381. https:\/\/doi.org\/10.3390\/ph15030381.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3534_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00374-w","volume":"18","author":"M Benvenuto","year":"2023","unstructured":"Benvenuto M, Angiolini V, Focaccetti C, Nardozi D, Palumbo C, Carrano R, et al. Antitumoral effects of bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo. Biol Direct. 2023;18:17. https:\/\/doi.org\/10.1186\/s13062-023-00374-w.","journal-title":"Biol Direct"},{"key":"3534_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/plants13030442","volume":"13","author":"AA Shaito","year":"2024","unstructured":"Shaito AA, Omairi I, Al-Thani N, Seglab F, Ad-Darwish E, Kobeissy F, et al. Determination of Medicago orbicularis antioxidant, antihemolytic, and anti-cancerous activities and its augmentation of cisplatin-induced cytotoxicity in A549 lung cancer cells. Plants (Basel). 2024;13:442. https:\/\/doi.org\/10.3390\/plants13030442.","journal-title":"Plants (Basel)"},{"key":"3534_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ph15020259","volume":"15","author":"SA Fahmy","year":"2022","unstructured":"Fahmy SA, Ponte F, Grande G, Fawzy IM, Mandour AA, Sicilia E, et al. Synthesis, characterization and host-guest complexation of asplatin: improved in vitro cytotoxicity and biocompatibility as compared to cisplatin. Pharmaceuticals (Basel). 2022;15:259. https:\/\/doi.org\/10.3390\/ph15020259.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3534_CR48","doi-asserted-by":"publisher","unstructured":"Luo Z, Zhu T, Luo W, Lv Y, Zhang L, Wang C, et al. Metformin induces apoptotic cytotoxicity depending on AMPK\/PKA\/GSK-3\u03b2-mediated c-FLIPL degradation in non-small cell lung cancer. Cancer Manag Res. 2019;681\u20139. https:\/\/doi.org\/10.2147\/CMAR.S178688","DOI":"10.2147\/CMAR.S178688"},{"key":"3534_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2025.101069","volume":"46","author":"N Sadeghi","year":"2026","unstructured":"Sadeghi N, Soleimanifar F, Attar E, Haddad Kashani H, Ghayoumi R, Etesami S-A. Pro-apoptotic effects of metformin and cisplatin in non-small cell Lung Cancer: Modulation of apoptosis-related genes and LncRNAs. Cancer Treat Res Commun. 2026;46:101069. https:\/\/doi.org\/10.1016\/j.ctarc.2025.101069.","journal-title":"Cancer Treat Res Commun"},{"key":"3534_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-36607-x","author":"SA Ali","year":"2026","unstructured":"Ali SA, Helmy HI, Gaber MH. Comparative in vitro cytotoxicity of free curcumin and a liposomal curcumin formulation on various human cancer cell lines. Sci Rep. 2026. https:\/\/doi.org\/10.1038\/s41598-026-36607-x.","journal-title":"Sci Rep"},{"key":"3534_CR51","doi-asserted-by":"publisher","unstructured":"Ka\u00e7ar S, Tomsuk \u00d6, \u015eahint\u00fcrk V. Curcumin has lower IC50 values against A549 lung cancer cells. bioRxiv. 2023;2008\u201323. https:\/\/doi.org\/10.1101\/2023.08.06.552182","DOI":"10.1101\/2023.08.06.552182"},{"key":"3534_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158248","author":"M-F Wu","year":"2022","unstructured":"Wu M-F, Huang Y-H, Chiu L-Y, Cherng S-H, Sheu G-T, Yang T-Y. Curcumin induces apoptosis of chemoresistant lung cancer cells via ROS-regulated p38 MAPK phosphorylation. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23158248.","journal-title":"Int J Mol Sci"},{"key":"3534_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21926\/obm.genet.2504313","volume":"9","author":"L Lo Bennett","year":"2025","unstructured":"Lo Bennett L. Potential synergistic interaction between curcumin and sorafenib enhances cytotoxicity in NCI-H5222 lung cancer cells. OBM Genet. 2025;9:1\u201316. https:\/\/doi.org\/10.21926\/obm.genet.2504313.","journal-title":"OBM Genet"},{"key":"3534_CR54","doi-asserted-by":"publisher","first-page":"6886366","DOI":"10.1155\/2022\/6886366","volume":"2022","author":"L Wang","year":"2022","unstructured":"Wang L, Hu R, Dai A. Curcumin Increased the Sensitivity of Non-Small-Cell Lung Cancer to Cisplatin through the Endoplasmic Reticulum Stress Pathway. Evidence-Based Complement Altern Med. 2022;2022:6886366. https:\/\/doi.org\/10.1155\/2022\/6886366.","journal-title":"Evidence-Based Complement Altern Med"},{"key":"3534_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26041056","volume":"26","author":"N Abdul Satar","year":"2021","unstructured":"Abdul Satar N, Ismail MN, Yahaya BH. Synergistic roles of curcumin in sensitising the cisplatin effect on a cancer stem cell-like population derived from non-small cell lung cancer cell lines. Molecules. 2021;26:1056. https:\/\/doi.org\/10.3390\/molecules26041056.","journal-title":"Molecules"},{"key":"3534_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/biof.2137","volume":"51","author":"H Chuang","year":"2025","unstructured":"Chuang H, Chan H, Shih K. Suppression of colorectal cancer growth: interplay between curcumin and metformin through DMT1 downregulation and ROS\u2010mediated pathways. BioFactors. 2025;51:e2137. https:\/\/doi.org\/10.1002\/biof.2137.","journal-title":"BioFactors"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03534-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03534-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03534-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:59:34Z","timestamp":1789149574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03534-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3534"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03534-z","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent to Publish declaration: not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of \u201cSolid dispersion of curcumin enhances the cytotoxic activity of conventional chemotherapeutic agents in lung cancer cells\u201d declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"294"}}